Attenuation of Flightless I, an actin-remodelling protein, improves burn injury repair via modulation of transforming growth factor (TGF)-β1 and TGF-β3
- 21 July 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 161 (2) , 326-336
Abstract
Background The pathophysiological mechanisms involved in burn injury repair are still not fully understood but include processes involving cellular proliferation, migration and adhesion. The actin cytoskeleton is intricately involved in these key wound repair processes. Flightless I (Flii), an actin‐remodelling protein and transcriptional regulator, is an important regulator of wound healing. Objectives To investigate the function of Flii gene expression in burn injury repair. Methods Partial‐thickness scald wounds were created on Flii heterozygous (Flii+/−), wild‐type (WT) and Flii transgenic (FliiTg/+) mice. Burns were assessed using histology and immunohistochemistry, real‐time quantitative polymerase chain reaction and biochemical analysis. Results Flii expression, while upregulated in burn injuries, was significantly lower in the wounds of Flii+/− vs. WT vs. FliiTg/+ mice and healing was improved in Flii+/− mice with their burns healing faster than WT and FliiTg/+. Pro‐scarring transforming growth factor (TGF)‐β1 protein and gene expression were reduced in Flii+/− burns while antiscarring TGF‐β3 was significantly elevated. Anti‐α‐smooth muscle actin (α‐SMA) was decreased in Flii+/− burns suggesting a decrease in contractile myofibroblasts in the developing scars. Although Flii is primarily a nuclear and cytoplasmic protein it is also released by wounded cells. Intradermal injection of Flii‐neutralizing antibodies (FliAbs) to WT burn wounds significantly improved their healing, indicating a potential novel approach for treating burns. Decreased TGF‐β1 and elevated TGF‐β3 expression were observed in FliAb‐treated burns, which may contribute to their observed improvement in healing. Conclusions Strategies aimed at reducing Flii expression, for example using neutralizing antibodies, may lead to improved burn outcomes.Keywords
This publication has 26 references indexed in Scilit:
- Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFβ3): from laboratory discovery to clinical pharmaceuticalJournal of Biomaterials Science, Polymer Edition, 2008
- Interplay of Fli-I and FLAP1 for regulation of β-catenin dependent transcriptionNucleic Acids Research, 2006
- Perspective Article: Tissue repair, contraction, and the myofibroblastWound Repair and Regeneration, 2005
- Developmentally Essential Protein Flightless I Is a Nuclear Receptor Coactivator with Actin Binding ActivityMolecular and Cellular Biology, 2004
- Differential Effect of Wounding on Actin and its Associated Proteins, Paxillin and Gelsolin, in Fetal Skin ExplantsJournal of Investigative Dermatology, 2003
- Synthetic TGF‐β antagonist accelerates wound healing and reduces scarringThe FASEB Journal, 2002
- The flightless I protein localizes to actin‐based structures during embryonic developmentImmunology & Cell Biology, 2000
- Cytoskeleton regulates expression of genes for transforming growth factor-β1 and extracellular matrix proteins in dermal fibroblastsJournal of Cellular Physiology, 1997
- From wound to scarBurns, 1996
- Alteration of Cell Morphology Triggers Transforming Growth Factor-β1, Collagenase, and Tissue Inhibitor of Metalloproteinases-I Expression in Normal and Hypertrophic Scar FibroblastsJournal of Investigative Dermatology, 1995